Skip to content

Representatives Reed, DeGette push for legislative action on insulin prices

Rep. Tom Reed (R-23) says he’s concerned about the price of insulin, and is hopeful that Congress will act on changes to lower prices.

In a conference call with reporters last week, Reed said he’s seen the price of insulin, a must for Type 1 diabetics, climb from a list price of about $68 a vial in 2006 to $300 in 2019, according to the Finger Lakes Times.

Insulin is one of many life-saving drugs whose prices Reed said have “skyrocketed” over the past decade and more, forcing some people to stretch or go without the medicine — “which is something a diabetic cannot do,” he said.

He urged Congress to take immediate action. He’s teamed up with Colorado Democrat Diana DeGette to push for the change.

Categories: HealthNewsPolitics